Advanced in Endometritis

Dr. Stephanie V. Blank

Gynecologic Oncology | Oncology
Icahn School Of Medicine At Mount Sinai
325 W 15th St, 
New York, NY 
Offers Telehealth
Advanced in Endometritis
Icahn School Of Medicine At Mount Sinai
325 W 15th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Stephanie Blank is a Gynecologic Oncologist and an Oncologist in New York, New York. Dr. Blank is rated as an Advanced provider by MediFind in the treatment of Endometritis. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Oophorectomy, and Hysterectomy.

Her clinical research consists of co-authoring 131 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Oncology
Licenses
Obstetrics & Gynecology in NY
Hospital Affiliations
Mount Sinai Beth Israel
Mount Sinai Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
325 W 15th St, New York, NY 10011
Other Locations
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 Gustave Levy Place, Mount Sinai Emergency Room, New York, NY 10029

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 01, 2025
Intervention Type: Drug, Procedure, Other
Study Drugs: Carboplatin, Cediranib Maleate, Gemcitabine, Gemcitabine Hydrochloride, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride
Study Phase: Phase 3
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
A Randomized, Double-blind, Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 13, 2025
Intervention Type: Drug
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 3
A Phase 2, Multicenter, Single Arm, Open Label Study to Evaluate the Efficacy and Safety of AK104 in Subjects With Recurrent or Metastatic Cervical Cancer
A Phase 2, Multicenter, Single Arm, Open Label Study to Evaluate the Efficacy and Safety of AK104 in Subjects With Recurrent or Metastatic Cervical Cancer
Enrollment Status: Completed
Publish Date: February 28, 2025
Intervention Type: Biological
Study Drug: AK104
Study Phase: Phase 2
Open Label Phase 2 Study of Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With a Safety Run-in of a Dose-Dense Regimen
Open Label Phase 2 Study of Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With a Safety Run-in of a Dose-Dense Regimen
Enrollment Status: Completed
Publish Date: May 06, 2023
Intervention Type: Drug
Study Drug: Tisotumab vedotin
Study Phase: Phase 2
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Paclitaxel
Study Phase: Phase 3
A Phase Ib Safety Run-in and Randomized Phase II, Open-label Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of M6620 in Combination With Avelumab and Carboplatin in Comparison to Standard of Care Therapy in Participants With PARPi-resistant Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Phase Ib Safety Run-in and Randomized Phase II, Open-label Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of M6620 in Combination With Avelumab and Carboplatin in Comparison to Standard of Care Therapy in Participants With PARPi-resistant Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Enrollment Status: Completed
Publish Date: November 13, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

131 Total Publications

Survival After Fertility-Preserving Hormonal Therapy vs Hysterectomy for Early-Stage Endometrial Cancer.
Survival After Fertility-Preserving Hormonal Therapy vs Hysterectomy for Early-Stage Endometrial Cancer.
Journal: JAMA oncology
Published: August 28, 2025
Similar Doctors
Distinguished in Endometritis
Dr. Konstantin Zakashansky
Gynecologic Oncology | Obstetrics and Gynecology | Oncology
Distinguished in Endometritis
Dr. Konstantin Zakashansky
Gynecologic Oncology | Obstetrics and Gynecology | Oncology

Icahn School Of Medicine At Mount Sinai

1000 10th Ave, 
New York, NY 
 (2.2 miles away)
212-523-4000
Languages Spoken:
English
See accepted insurances

Konstantin Zakashansky is a Gynecologic Oncologist and an Obstetrics and Gynecologist in New York, New York. Dr. Zakashansky is rated as a Distinguished provider by MediFind in the treatment of Endometritis. His top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Endometrial Polyps, Oophorectomy, and Hysterectomy.

Dr. Dmitriy Bronfman
Distinguished in Endometritis
Dr. Dr. Dmitriy Bronfman
Gynecologic Oncology
Distinguished in Endometritis
Dr. Dr. Dmitriy Bronfman
Gynecologic Oncology

Brooklyn Abortion Clinic

14 DeKalb Ave, 4 floor, 
Brooklyn, NY 
 (3.7 miles away)
718-369-1900
Languages Spoken:
English, Creole, French, Russian, Spanish, Ukrainian
See accepted insurances
Offers Telehealth

Dmitriy Bronfman, MD is a practicing OBGYN (Obstetrician & Gynecologist) in Brooklyn, NY. Dr. Bronfman graduated from Mount Sinai School of Medicine of New York University in 1998 and has been in practice for 19 years. He completed a residency at Brooklyn Hospital Center. Dr. Bronfman also specializes in Obstetrics and Gynecology. He currently practices at Professional Gynecological Services and is affiliated with Lutheran Medical Center, New York Methodist Hospital and The Brooklyn Hospital Center. Dr. Bronfman accepts multiple insurance plans including Aetna, MVP Health Plan and Medicare. Dr. Bronfman also practices at Manhattan Beach Ob/Gyn in Brooklyn, NY.Specialties: OBGYN (Obstetrics & Gynecology) Education: Medical School — Icahn School of Medicine at Mount Sinai, Doctor of Medicine. The Brooklyn Hospital Center, Residency in Obstetrics and Gynecology. Dr. Bronfman is rated as a Distinguished provider by MediFind in the treatment of Endometritis. His top areas of expertise are Pelvic Congestion Syndrome, Hydrocele, Trichomoniasis, Pelvic Inflammatory Disease, and Intrauterine Device Insertion.

Advanced in Endometritis
Dr. Daniel H. Tobias
Gynecologic Oncology | Obstetrics and Gynecology
Advanced in Endometritis
Dr. Daniel H. Tobias
Gynecologic Oncology | Obstetrics and Gynecology

Practice Associates Medical Group

33 Overlook Rd, Suite 207, 
Summit, NJ 
 (18.4 miles away)
908-598-6517
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daniel Tobias is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Summit, New Jersey. Dr. Tobias is rated as a Distinguished provider by MediFind in the treatment of Endometritis. His top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Tobias is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Blank's expertise for a condition
ConditionClose
View All 22 Advanced Conditions
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile